chupert

Great news! I will keep an eye on the Hemobioscience website for when it comes available. Thanks.

Does anyone in the U.S. know of a manufacturer who still makes a lectin kit to investigate polyagglutination? Thanks!

We store treated cells in Alsever's solution but wash and resuspend them in normal saline for testing. We have also tested these patients with freshly treated cells that haven't been in Alsever's and still get the reactions. Thanks for the input.

They are receiving anti-cd38, specifically daratumumab.

Has anyone else come across patients receiving daratumumab where the DTT treated screen is still reactive? I work at a reference lab in a large hospital with a very large population of multiple myeloma patients and have come across 3 such patients. We have tested DTT treated panels and usually see panreactivity give or take a cell or 2 every now and then. In all 3 the plasma was non-reactive with untreated cord cells, autologous cells and red cells from a few other patients receiving dara. Interestingly when we DTT treated the cord cells, AC and cells from other dara patients, we got posit

I am considering getting my master's and was looking for input. Has anyone been through GWU master's in immunohematology and biotechnology program or UTMB master's in transfusion medicine? I am also considering a more general master's in CLS. Thanks for any info you can send my way.

So just curious if anyone has any thoughts about this case...The patient is pregnant with no history of blood transfusions and types B neg with panagglutination in her antibody screen (all 3 cells 3+) by solid phase testing. A solid phase panel also shows panagglutination with scores ranging from 3-4. A PEG panel shows weak reactivity with some, but not all of the Rh positive cells and all Rh neg cells are negative. The patient did receive Rhogam about 2 months ago. All clinically significant aby's have been ruled out, so I'm thinking a Rhig-D and solid phase is just....well being solid ph